Skip To Main Content

Určeno pro odbornou veřejnost

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Číst více

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Číst více

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Číst více

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Číst více

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Číst více

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Číst více

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Číst více

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Číst více

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Číst více

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Číst více

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Číst více

Risk for Post-operative Venous Thromboembolism in Patients Receiving Enoxaparin Prophylaxis

Risk for Post-operative Venous Thromboembolism in Patients Receiving Enoxaparin Prophylaxis

Low anti-Factor Xa indicative of inadequate enoxaparin dosing is associated with a higher incidence of post-surgical Venous Thromboembolism.

Číst více